Skip to main content
. Author manuscript; available in PMC: 2010 Nov 9.
Published in final edited form as: Prostate. 2009 Jul 1;69(10):1128–1141. doi: 10.1002/pros.20962

Fig. 7.

Fig. 7

In vivo specificity and infection efficiency of MVG-αPSMA virus. Tumor xenografts were injected intratumorally with one dose of 2 ×106TCID50 virus and harvested 4 days later. Tumors were cryosectioned and immunostaining for MV-nucleocapsid N protein (brown color) was performed. MVG-αPSMA virus efficiently infected PSMA positive LNCaP and PC3/PIP tumors. In contrast, PSMA negative tumor PC3 showed little or no infection by the MVG-αPSMA virus.